Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Frontiers in Pharmacology|June 27, 2024
The role of autophagy in Parkinson's disease: a gender difference overviewLaura Cucinotta, Deborah Mannino, Alessia Filippone, et al.
Antioxidants (Basel, Switzerland)|September 23, 2022
LRRK2 Inhibition by PF06447475 Antagonist Modulates Early Neuronal Damage after Spinal Cord TraumaAlessia Filippone, Deborah Mannino, Laura Cucinotta, et al.
Experimental Eye Research|October 25, 2025
Inhibition of Enhancer of Zeste Homolog 2 alleviates oxidative stress, inflammation and barrier damage of human corneal epithelial cellsSarah Adriana Scuderi, Nicoletta Palermo, Laura Cucinotta, et al.
Iscience|December 5, 2024
Rebalance of mitophagy by inhibiting LRRK2 improves colon alterations in an MPTP <i>in vivo</i> modelAlessia Filippone, Deborah Mannino, Laura Cucinotta, et al.
Biomedicines|April 23, 2022
Effect of Melatonin on Psoriatic Phenotype in Human Reconstructed Skin ModelSarah Adriana Scuderi, Laura Cucinotta, Alessia Filippone, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 5, 2025
Targeting enhancer of zeste homolog 2: A novel therapeutic approach for head and neck cancerSarah Adriana Scuderi, Laura Cucinotta, Rossella Basilotta, et al.
Respiratory Research|August 25, 2023
Prolyl oligopeptidase inhibition ameliorates experimental pulmonary fibrosis both in vivo and in vitroLaura Cucinotta, Deborah Mannino, Giovanna Casili, et al.
Antioxidants (Basel, Switzerland)|April 29, 2025
The Inhibition of Prolyl Endopeptidase (PREP) by KYP-2047 Treatment to Reduce Myocardial Ischemia/Reperfusion InjuryLaura Cucinotta, Nicoletta Palermo, Alessio Ardizzone, et al.
Cells|April 13, 2023
Inhibition of LRRK2 Attenuates Depression-Related Symptoms in Mice with Moderate Traumatic Brain InjuryAlessia Filippone, Laura Cucinotta, Valentina Bova, et al.
Pageof 2